We leveraged our dataset as a tool to validate previously reported data by testing the frequency of CD3+CD56+ regulatory T cells (25), defined as TR3-56 cells, recently described to be reduced in patients with newly diagnosed type 1 diabetes compared to HC. Here, NCAM1 is linked to type 1 diabetes mellitus.